Avalon Investment & Advisory’s iShares Biotechnology ETF IBB Stock Holding History

Avalon Investment & Advisory’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-22,086	Closed	-$3.35M	–	357
2020 Q4	$3.35M	Buy	+22,086	New	+$3.16M	0.07%	162
2018 Q1	–	Sell	-3,225	Closed	-$344K	–	360
2017 Q4	$344K	Sell	3,225 -5,256	-62%	-$562K	0.01%	323
2017 Q3	$943K	Buy	8,481 +3,228	+61%	+$345K	0.03%	259
2017 Q2	$543K	Buy	+5,253	New	+$517K	0.02%	314

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Avalon Investment & Advisory's IBB Position: Q1 2021 in Review

Avalon Investment & Advisory sold out of iShares Biotechnology ETF (IBB) in Q1 2021, closing a stake of 22,086 shares — an estimated $3.35M sold.

Avalon Investment & Advisory first reported a position in IBB in Q2 2017 and held it in 4 quarters. The position peaked at $3.35M in Q4 2020. 845 funds tracked by Wall St. Rank hold IBB as of Q1 2021.

Avalon Investment & Advisory reported no remaining iShares Biotechnology ETF position as of Q1 2021 after selling out during the quarter.
Avalon Investment & Advisory sold 22,086 iShares Biotechnology ETF shares in Q1 2021, an estimated $3.35M.
Avalon Investment & Advisory first reported a position in iShares Biotechnology ETF in Q2 2017 and held it in 4 quarters.
Avalon Investment & Advisory's iShares Biotechnology ETF position peaked at $3.35M in Q4 2020.
845 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2021.

Based on Avalon Investment & Advisory's 13F filing for Q1 2021, filed 13 May 2021.